Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Fund Focus: Oppenheimer Global Fund

FYI: he recent volatility in the global stock market may make some investors feel queasy, but it is providing a buying opportunity in biotechnology stocks.

That is because biotechs will see little impact from rising interest rates because investors are more focused on the long-term potential of their drugs, said Rajeev Bhaman, portfolio manager of the $11.8 billion Oppenheimer Global fund. You can see the full list of Lipper U.S. award winners
Regards,
Ted
https://www.fa-mag.com/news/why-oppenheimer-global-fund-is-focusing-on-biotech-as-rates-rise-37408.html?print

M* Snapshot OPPAX:
http://www.morningstar.com/funds/XNAS/OPPAX/quote.html

Lipper Snapshot OPPAX:
https://www.marketwatch.com/investing/fund/oppax

OPPAX Ranks #11 In The (WLCS) Fund Category By U.S. News & World Report:
https://money.usnews.com/funds/mutual-funds/world-large-stock/oppenheimer-global-fund/oppax
Sign In or Register to comment.